Deleted Tweets From Scott Gottlieb, R-D.C.

RT @FrankYiannasFDA: During the partial shutdown, @US_FDA continues to promptly respond to recalls. RXBAR Recalls Certain Varieties of Bars Due to a Potential Undeclared Peanut Allergen. More info at https://t.co/beP2XMpdJT

RT @lauriemcginley2: FDA to expand ranks of cell and gene therapy reviewers as INDs increase https://t.co/dfY75BoRny

.... You’re valued each day. But it’s even more the case that in moments of challenge, when some of our work stops, that your critical role becomes so obvious. FDA can’t achieve its full mission without each of you; whether you’re exempt, excepted, or on furlough. We’re one FDA.

THREAD: Some of the dedicated FDA staff of our Office of Regulatory Affairs at work, unpaid, in our Philadelphia lab. We’ve restarted high risk food sampling assignments and other critical surveillance activity. Among many hardships our people are overcoming right now .... https://t.co/DtnJxe2Cw5

.... one of the hardest challenges is to find yourself on furlough. All of our colleagues are critical; all do critical work to advance public health. I highly value each and every one of you, the institution depends on all of you....

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, on unprecedented new efforts to support development of over-the-coun… https://t.co/cJNVuAGkBf

The cause is yet to be determined, but we’re reviewing all available information quickly and thoroughly and will communicate as soon as we know more.

Today we alerted health care professionals about possible increased risk of death in certain patients with peripheral arterial disease being treated with a type of drug-containing balloon or stent. https://t.co/hcVUn0cXVI

My statement on the unprecedented work done by #FDA to proactively design, test and validate the key labeling requirements necessary to approve an OTC version of naloxone and make it available to patients. https://t.co/YOG2TXo96n https://t.co/10aPCTsLWN

The identification of this risk, and our work to notify patients and providers, reinforces why post-market surveillance of medical devices is pivotal and why our ongoing investment in these capabilities is a key part of our work to protect patients

While we agree with the premise that prevention is always better than a corrective action, such as executing a recall, there should be caution in using recall numbers alone as the sole metric for gauging long-term performance trends in food safety.

THREAD: We appreciate US PIRG’s interest in the safety of the nation’s food system and we always welcome a larger conversation on the topic. Public health is our top priority and FDA is working hard to ensure the U.S. food supply remains among the safest in the world.

Dramatic improvements in new tools to detect foodborne pathogens has likely resulted in an increased # of recalls. The complexity of supply chain for foods has also increased so one contaminated ingredient can trigger many recalls, which can affect the overall number of recalls.

FDA ensures that recalls by companies – voluntary or involuntary – are initiated, overseen, and completed promptly and effectively, and that consumers have timely, actionable information to protect themselves and their families.

Even during the lapse in funding, we're continuing to support recalls as necessary to identify and respond to threats to the safety of human life, and activities for the surveillance and inspection of high-risk foods.

THREAD: A new @AmJPrevMed supplement published today highlights the success #FDA’s groundbreaking “The Real Cost” youth smoking prevention campaign has had over the last five years to change teens’ knowledge, attitudes and beliefs about smoking: https://t.co/aqDpApixOh https://t.co/Ak44Z9u37U

RT @FDATobacco: In addition to saving kids’ lives, FDA’s “The Real Cost” campaign has saved $31+ billion by reducing smoking-relate… https://t.co/9agDWTuqZf

More actions to improve our recall policies are planned, including ways to further improve our ability to track and trace products through the supply chain. We’ll continue to communicate on these efforts in the coming year.

Over the past year, #FDA has made several key policy changes to improve and modernize its food recall processes -- with a focus on providing more meaningful information to consumers.

RT @FDATobacco: True or False? Smoking just affects the lungs and heart. ❌ False ❌ Smoking can cause cervical cancer. Learn mo… https://t.co/fJbOOFTzfe

RT @FrankYiannasFDA: During the partial shutdown, @US_FDA continues to promptly respond to recalls. RXBAR Recalls Certain Varieties of Bars Due to a Potential Undeclared Peanut Allergen. More info at https://t.co/beP2XMpdJT

RT @lauriemcginley2: FDA to expand ranks of cell and gene therapy reviewers as INDs increase https://t.co/dfY75BoRny

.... You’re valued each day. But it’s even more the case that in moments of challenge, when some of our work stops, that your critical role becomes so obvious. FDA can’t achieve its full mission without each of you; whether you’re exempt, excepted, or on furlough. We’re one FDA.

THREAD: Some of the dedicated FDA staff of our Office of Regulatory Affairs at work, unpaid, in our Philadelphia lab. We’ve restarted high risk food sampling assignments and other critical surveillance activity. Among many hardships our people are overcoming right now .... https://t.co/DtnJxe2Cw5

.... one of the hardest challenges is to find yourself on furlough. All of our colleagues are critical; all do critical work to advance public health. I highly value each and every one of you, the institution depends on all of you....

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, on unprecedented new efforts to support development of over-the-coun… https://t.co/cJNVuAGkBf

The cause is yet to be determined, but we’re reviewing all available information quickly and thoroughly and will communicate as soon as we know more.

Today we alerted health care professionals about possible increased risk of death in certain patients with peripheral arterial disease being treated with a type of drug-containing balloon or stent. https://t.co/hcVUn0cXVI

My statement on the unprecedented work done by #FDA to proactively design, test and validate the key labeling requirements necessary to approve an OTC version of naloxone and make it available to patients. https://t.co/YOG2TXo96n https://t.co/10aPCTsLWN

The identification of this risk, and our work to notify patients and providers, reinforces why post-market surveillance of medical devices is pivotal and why our ongoing investment in these capabilities is a key part of our work to protect patients

While we agree with the premise that prevention is always better than a corrective action, such as executing a recall, there should be caution in using recall numbers alone as the sole metric for gauging long-term performance trends in food safety.

THREAD: We appreciate US PIRG’s interest in the safety of the nation’s food system and we always welcome a larger conversation on the topic. Public health is our top priority and FDA is working hard to ensure the U.S. food supply remains among the safest in the world.

Dramatic improvements in new tools to detect foodborne pathogens has likely resulted in an increased # of recalls. The complexity of supply chain for foods has also increased so one contaminated ingredient can trigger many recalls, which can affect the overall number of recalls.

FDA ensures that recalls by companies – voluntary or involuntary – are initiated, overseen, and completed promptly and effectively, and that consumers have timely, actionable information to protect themselves and their families.

Even during the lapse in funding, we're continuing to support recalls as necessary to identify and respond to threats to the safety of human life, and activities for the surveillance and inspection of high-risk foods.

THREAD: A new @AmJPrevMed supplement published today highlights the success #FDA’s groundbreaking “The Real Cost” youth smoking prevention campaign has had over the last five years to change teens’ knowledge, attitudes and beliefs about smoking: https://t.co/aqDpApixOh https://t.co/Ak44Z9u37U

RT @FDATobacco: In addition to saving kids’ lives, FDA’s “The Real Cost” campaign has saved $31+ billion by reducing smoking-relate… https://t.co/9agDWTuqZf

More actions to improve our recall policies are planned, including ways to further improve our ability to track and trace products through the supply chain. We’ll continue to communicate on these efforts in the coming year.

Over the past year, #FDA has made several key policy changes to improve and modernize its food recall processes -- with a focus on providing more meaningful information to consumers.

RT @FDATobacco: True or False? Smoking just affects the lungs and heart. ❌ False ❌ Smoking can cause cervical cancer. Learn mo… https://t.co/fJbOOFTzfe